A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects

Summary

This study examines whether a gradual increase of dose improves the gastrointestinal tolerability (nausea and vomiting) of PF05212389

Timeline

Start

2011-04

Primary completion

2011-07

Completion

2011-08

Drugs

Indications